Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients.

Mercurio V, Lobasso A, Barbieri L, Parrella P, Ciervo D, Liccardo B, Bonaduce D, Tocchetti CG, De Paulis A, Rossi FW.

Int J Mol Sci. 2019 Apr 30;20(9). pii: E2154. doi: 10.3390/ijms20092154.

2.

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M.

Breast Cancer Res. 2019 Feb 1;21(1):20. doi: 10.1186/s13058-019-1104-5.

3.

The value of epigenetic biomarkers in breast cancer.

Parrella P.

Biomark Med. 2018 Sep;12(9):937-940. doi: 10.2217/bmm-2018-0187. Epub 2018 Jul 25. No abstract available.

4.

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.

Varricchi G, Ameri P, Cadeddu C, Ghigo A, Madonna R, Marone G, Mercurio V, Monte I, Novo G, Parrella P, Pirozzi F, Pecoraro A, Spallarossa P, Zito C, Mercuro G, Pagliaro P, Tocchetti CG.

Front Physiol. 2018 Mar 7;9:167. doi: 10.3389/fphys.2018.00167. eCollection 2018. Review.

5.

New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension.

Mercurio V, Bianco A, Campi G, Cuomo A, Diab N, Mancini A, Parrella P, Petretta M, Hassoun P, Bonaduce D.

Curr Med Chem. 2018 Jan 31. doi: 10.2174/0929867325666180201095743. [Epub ahead of print]

PMID:
29421995
6.

Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine.

Pasculli B, Barbano R, Parrella P.

Semin Cancer Biol. 2018 Aug;51:22-35. doi: 10.1016/j.semcancer.2018.01.007. Epub 2018 Jan 12. Review.

PMID:
29339244
7.

Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.

Barbano R, Pasculli B, Rendina M, Fontana A, Fusilli C, Copetti M, Castellana S, Valori VM, Morritti M, Graziano P, Luigi C, Coco M, Picardo F, Mazza T, Evron E, Murgo R, Maiello E, Esteller M, Fazio VM, Parrella P.

Sci Rep. 2017 Mar 27;7:45283. doi: 10.1038/srep45283.

8.

Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond.

Di Lisi D, Madonna R, Zito C, Bronte E, Badalamenti G, Parrella P, Monte I, Tocchetti CG, Russo A, Novo G.

Int J Cardiol. 2017 Jan 15;227:11-17. doi: 10.1016/j.ijcard.2016.11.174. Epub 2016 Nov 9. Review.

PMID:
27866063
9.

Biomarkers in sarcopenia: A multifactorial approach.

Curcio F, Ferro G, Basile C, Liguori I, Parrella P, Pirozzi F, Della-Morte D, Gargiulo G, Testa G, Tocchetti CG, Bonaduce D, Abete P.

Exp Gerontol. 2016 Dec 1;85:1-8. doi: 10.1016/j.exger.2016.09.007. Epub 2016 Sep 12. Review.

PMID:
27633530
10.

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

Roma C, Rachiglio AM, Pasquale R, Fenizia F, Iannaccone A, Tatangelo F, Antinolfi G, Parrella P, Graziano P, Sabatino L, Colantuoni V, Botti G, Maiello E, Normanno N.

Cancer Biol Ther. 2016 Aug 2;17(8):840-8. doi: 10.1080/15384047.2016.1195048.

11.

Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.

Barbano R, Pasculli B, Coco M, Fontana A, Copetti M, Rendina M, Valori VM, Graziano P, Maiello E, Fazio VM, Parrella P.

Sci Rep. 2015 Dec 22;5:18592. doi: 10.1038/srep18592.

12.

Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.

Sestito S, Nesi G, Daniele S, Martelli A, Digiacomo M, Borghini A, Pietra D, Calderone V, Lapucci A, Falasca M, Parrella P, Notarangelo A, Breschi MC, Macchia M, Martini C, Rapposelli S.

Eur J Med Chem. 2015 Nov 13;105:274-88. doi: 10.1016/j.ejmech.2015.10.020. Epub 2015 Oct 22.

PMID:
26498573
13.

TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival.

Micale L, Fusco C, Fontana A, Barbano R, Augello B, De Nittis P, Copetti M, Pellico MT, Mandriani B, Cocciadiferro D, Parrella P, Fazio VM, Dimitri LM, D'Angelo V, Novielli C, Larizza L, Daga A, Merla G.

BMC Cancer. 2015 Jun 16;15:470. doi: 10.1186/s12885-015-1449-9.

14.

A miRNA signature for defining aggressive phenotype and prognosis in gliomas.

Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P.

PLoS One. 2014 Oct 3;9(10):e108950. doi: 10.1371/journal.pone.0108950. eCollection 2014.

15.

Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

Parrella P, Barbano R, Pasculli B, Fontana A, Copetti M, Valori VM, Poeta ML, Perrone G, Righi D, Castelvetere M, Coco M, Balsamo T, Morritti M, Pellegrini F, Onetti-Muda A, Maiello E, Murgo R, Fazio VM.

Mol Cancer. 2014 Jun 4;13:142. doi: 10.1186/1476-4598-13-142.

16.

Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme.

Notarangelo A, Trombetta D, D'Angelo V, Parrella P, Palumbo O, Storlazzi CT, Impera L, Muscarella LA, La Torre A, Affuso A, Fazio VM, Carella M, Zelante L.

Int J Oncol. 2014 Mar;44(3):717-24. doi: 10.3892/ijo.2013.2224. Epub 2013 Dec 23.

PMID:
24366606
17.

Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system.

Muscarella LA, la Torre A, Faienza A, Catapano D, Bisceglia M, D'Angelo V, Parrella P, Coco M, Fini G, Tancredi A, Zelante L, Fazio VM, D'Agruma L.

J Neuropathol Exp Neurol. 2014 Jan;73(1):50-8. doi: 10.1097/NEN.0000000000000024.

PMID:
24335534
18.

The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.

Lucá R, Averna M, Zalfa F, Vecchi M, Bianchi F, La Fata G, Del Nonno F, Nardacci R, Bianchi M, Nuciforo P, Munck S, Parrella P, Moura R, Signori E, Alston R, Kuchnio A, Farace MG, Fazio VM, Piacentini M, De Strooper B, Achsel T, Neri G, Neven P, Evans DG, Carmeliet P, Mazzone M, Bagni C.

EMBO Mol Med. 2013 Oct;5(10):1523-36. doi: 10.1002/emmm.201302847. Epub 2013 Sep 16. Erratum in: EMBO Mol Med. 2014 Apr;6(4):567.

19.

VHL gene alterations in Italian patients with isolated renal cell carcinomas.

Muscarella LA, D'Agruma L, la Torre A, Gigante M, Coco M, Parrella P, Battaglia M, Carrieri G, Carella M, Zelante L, Fazio VM, Gesualdo L, Ranieri E.

Int J Biol Markers. 2013 Jun 28;28(2):208-15. doi: 10.5301/jbm.5000011.

PMID:
23558940
20.

Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.

Brait M, Munari E, LeBron C, Noordhuis MG, Begum S, Michailidi C, Gonzalez-Roibon N, Maldonado L, Sen T, Guerrero-Preston R, Cope L, Parrella P, Fazio VM, Ha PK, Netto GJ, Sidransky D, Hoque MO.

Cell Cycle. 2013 Apr 1;12(7):1058-70. doi: 10.4161/cc.24050. Epub 2013 Feb 22.

21.

Aberrant Keap1 methylation in breast cancer and association with clinicopathological features.

Barbano R, Muscarella LA, Pasculli B, Valori VM, Fontana A, Coco M, la Torre A, Balsamo T, Poeta ML, Marangi GF, Maiello E, Castelvetere M, Pellegrini F, Murgo R, Fazio VM, Parrella P.

Epigenetics. 2013 Jan;8(1):105-12. doi: 10.4161/epi.23319. Epub 2012 Dec 18.

22.

Aberrant genes promoter methylation in neural crest-derived tumors.

la Torre A, Muscarella LA, Parrella P, Balsamo T, Bisceglia M, Valori VM, la Torre A, Barbano R, Perrella E, Poeta ML, Melchionda G, Merla G, Maiello E, Pellicano R, Fazio VM.

Int J Biol Markers. 2012 Dec 27;27(4):e389-94. doi: 10.5301/JBM.2012.9766.

PMID:
23125005
23.

Hormone and cytokine circadian alteration in non-small cell lung cancer patients.

Mazzoccoli G, Sothern RB, Francavilla M, Giuliani F, Carughi S, Muscarella LA, Fazio VM, Parrella P, Vinciguerra M, Tarquini R.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):691-702.

PMID:
23058019
24.

Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.

Poeta ML, Massi E, Parrella P, Pellegrini P, De Robertis M, Copetti M, Rabitti C, Perrone G, Muda AO, Molinari F, Zanellato E, Crippa S, Caputo D, Caricato M, Frattini M, Coppola R, Fazio VM.

Genes Chromosomes Cancer. 2012 Dec;51(12):1133-43. doi: 10.1002/gcc.21998. Epub 2012 Aug 25.

PMID:
22927297
25.

Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score.

Senni M, Parrella P, De Maria R, Cottini C, Böhm M, Ponikowski P, Filippatos G, Tribouilloy C, Di Lenarda A, Oliva F, Pulignano G, Cicoira M, Nodari S, Porcu M, Cioffi G, Gabrielli D, Parodi O, Ferrazzi P, Gavazzi A.

Int J Cardiol. 2013 Feb 20;163(2):206-11. doi: 10.1016/j.ijcard.2011.10.071. Epub 2011 Nov 29.

PMID:
22130225
26.

Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls.

Mazzoccoli G, Sothern RB, Parrella P, Muscarella LA, Fazio VM, Giuliani F, Polyakova V, Kvetnoy IM.

Clin Exp Med. 2012 Sep;12(3):181-94. doi: 10.1007/s10238-011-0153-6. Epub 2011 Sep 11.

PMID:
21910027
27.

Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer.

Muscarella LA, Parrella P, D'Alessandro V, la Torre A, Barbano R, Fontana A, Tancredi A, Guarnieri V, Balsamo T, Coco M, Copetti M, Pellegrini F, De Bonis P, Bisceglia M, Scaramuzzi G, Maiello E, Valori VM, Merla G, Vendemiale G, Fazio VM.

Epigenetics. 2011 Jun;6(6):710-9. Epub 2011 Jun 1.

PMID:
21610322
28.

Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.

Muscarella LA, D'Alessandro V, la Torre A, Copetti M, De Cata A, Parrella P, Sperandeo M, Pellegrini F, Frusciante V, Maiello E, Merla G, Fazio VM, Vendemiale G.

Cell Oncol (Dordr). 2011 Oct;34(5):435-41. doi: 10.1007/s13402-011-0025-9. Epub 2011 Apr 19.

PMID:
21503779
29.

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study.

Colucci G, Giuliani F, Garufi C, Mattioli R, Manzione L, Russo A, Lopez M, Parrella P, Tommasi S, Copetti M, Daniele B, Pisconti S, Tuveri G, Silvestris N, Maiello E.

Oncology. 2010;79(5-6):415-22. doi: 10.1159/000323279. Epub 2011 Apr 7.

PMID:
21474966
30.

Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.

Muscarella LA, Barbano R, D'Angelo V, Copetti M, Coco M, Balsamo T, la Torre A, Notarangelo A, Troiano M, Parisi S, Icolaro N, Catapano D, Valori VM, Pellegrini F, Merla G, Carella M, Fazio VM, Parrella P.

Epigenetics. 2011 Mar;6(3):317-25. Epub 2011 Mar 1.

31.

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome.

Barbano R, Copetti M, Perrone G, Pazienza V, Muscarella LA, Balsamo T, Storlazzi CT, Ripoli M, Rinaldi M, Valori VM, Latiano TP, Maiello E, Stanziale P, Carella M, Mangia A, Pellegrini F, Bisceglia M, Muda AO, Altomare V, Murgo R, Fazio VM, Parrella P.

Int J Cancer. 2011 Aug 1;129(3):536-45. doi: 10.1002/ijc.25736. Epub 2010 Dec 9.

32.

Epigenetic Signatures in Breast Cancer: Clinical Perspective.

Parrella P.

Breast Care (Basel). 2010;5(2):66-73. Epub 2010 Apr 23.

33.

Small deletion at the 7q21.2 locus in a CCM family detected by real-time quantitative PCR.

Muscarella LA, Guarnieri V, Coco M, Belli S, Parrella P, Pulcrano G, Catapano D, D'Angelo VA, Zelante L, D'Agruma L.

J Biomed Biotechnol. 2010;2010. pii: 854737. doi: 10.1155/2010/854737. Epub 2010 Jul 27.

34.

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2694-700. doi: 10.1158/1055-9965.EPI-08-0821. Epub 2009 Sep 29.

35.

High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas.

Parrella P, la Torre A, Copetti M, Valori VM, Barbano R, Notarangelo A, Bisceglia M, Gallo AP, Balsamo T, Poeta ML, Carella M, Catapano D, Parisi S, Dallapiccola B, Maiello E, D'Angelo V, Fazio VM.

J Biomed Biotechnol. 2009;2009:531692. doi: 10.1155/2009/531692. Epub 2009 Jun 1.

36.

Comparison between real-time quantitative PCR detection of HER2 mRNA copy number in peripheral blood and ELISA of serum HER2 protein for determining HER2 status in breast cancer patients.

Savino M, Parrella P, Copetti M, Barbano R, Murgo R, Fazio VM, Valori VM, Carella M, Garrubba M, Santini SA.

Cell Oncol. 2009;31(3):203-11. doi: 10.3233/CLO-2009-0468.

37.

Molecular analysis of the HuD gene in neuroendocrine lung cancers.

D'Alessandro V, Muscarella LA, la Torre A, Bisceglia M, Parrella P, Scaramuzzi G, Storlazzi CT, Trombetta D, Kok K, De Cata A, Sperandeo M, Zelante L, Carella M, Vendemiale G.

Lung Cancer. 2010 Jan;67(1):69-75. doi: 10.1016/j.lungcan.2009.03.022.

PMID:
19410329
38.

Surgical ventricular restoration by means of a new technique to preserve left ventricular compliance: the horseshoe repair.

Ferrazzi P, Triggiani M, Iacovoni A, Pentiricci S, Vattimo F, Parrella P, Quaini E.

J Thorac Cardiovasc Surg. 2008 Nov;136(5):1382-3. doi: 10.1016/j.jtcvs.2008.01.051. Epub 2008 Sep 6. No abstract available.

39.

Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration.

Chiarella P, Massi E, De Robertis M, Sibilio A, Parrella P, Fazio VM, Signori E.

Expert Opin Biol Ther. 2008 Nov;8(11):1645-57. doi: 10.1517/14712598.8.11.1645 .

PMID:
18847301
40.

Development of real-time quantitative reverse transcription-PCR for Her2 detection in peripheral blood from patients with breast cancer.

Savino M, Garrubba M, Parrella P, Baorda F, Copetti M, Murgo R, Zelante L, Carella M, Valori VM, Santini SA.

Clin Chim Acta. 2007 Sep;384(1-2):52-6. Epub 2007 Jun 6.

PMID:
17599819
41.

Epidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only.

Donatelli F, Vavassori A, Bonfanti S, Parrella P, Lorini L, Fumagalli R, Carli F.

Anesth Analg. 2007 Jun;104(6):1587-93, table of contents.

PMID:
17513663
42.

Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.

Scintu M, Vitale R, Prencipe M, Gallo AP, Bonghi L, Valori VM, Maiello E, Rinaldi M, Signori E, Rabitti C, Carella M, Dallapiccola B, Altomare V, Fazio VM, Parrella P.

Cancer Lett. 2007 Sep 8;254(2):298-307. Epub 2007 May 10.

PMID:
17498870
43.

Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection.

Parrella P, Seripa D, Matera MG, Rinaldi M, Signori E, Gravina C, Gallo AP, Prencipe M, Grandone E, Mariani L, Cordiali P, Di Carlo A, Stentella P, Pachì A, Fazio VM.

Eur J Epidemiol. 2007;22(3):159-62. Epub 2007 Feb 15.

PMID:
17380431
44.

Intraoperative infusion of amino acids induces anabolism independent of the type of anesthesia.

Donatelli F, Schricker T, Parrella P, Asenjo F, Wykes L, Carli F.

Anesth Analg. 2006 Dec;103(6):1549-56.

PMID:
17122238
45.

A novel prognostic index to determine the impact of cardiac conditions and co-morbidities on one-year outcome in patients with heart failure.

Senni M, Santilli G, Parrella P, De Maria R, Alari G, Berzuini C, Scuri M, Filippi A, Migliori M, Minetti B, Ferrazzi P, Gavazzi A.

Am J Cardiol. 2006 Oct 15;98(8):1076-82. Epub 2006 Aug 30.

PMID:
17027575
46.

Postoperative infusion of amino acids induces a positive protein balance independently of the type of analgesia used.

Donatelli F, Schricker T, Mistraletti G, Asenjo F, Parrella P, Wykes L, Carli F.

Anesthesiology. 2006 Aug;105(2):253-9.

PMID:
16871058
47.

[Cardiovascular medicine unit: preliminary results of an in-hospital multidisciplinary intervention in heart failure].

Senni M, Gori M, Alari G, Duino V, Siccardo R, Grosu A, Santilli G, Parrella P, Saronni P, Pezzoli F, Migliori M, Minetti B, Suter F, De Maria R, Ferrazzi P, Gavazzi A.

G Ital Cardiol (Rome). 2006 May;7(5):348-58. Italian.

PMID:
16752518
48.

Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer.

Parrella P, Mazzarelli P, Signori E, Perrone G, Marangi GF, Rabitti C, Delfino M, Prencipe M, Gallo AP, Rinaldi M, Fabbrocini G, Delfino S, Persichetti P, Fazio VM.

J Clin Pathol. 2006 Nov;59(11):1181-5. Epub 2006 Feb 23.

49.

Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: the relevance of the left ventricular equator as a prognostic factor.

Ferrazzi P, Matteucci ML, Merlo M, Iacovoni A, Rescigno G, Bottai M, Parrella P, Lorini L, Senni M, Gavazzi A.

J Thorac Cardiovasc Surg. 2006 Feb;131(2):357-63.

50.

DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor.

Mazzarelli P, Parrella P, Seripa D, Signori E, Perrone G, Rabitti C, Borzomati D, Gabbrielli A, Matera MG, Gravina C, Caricato M, Poeta ML, Rinaldi M, Valeri S, Coppola R, Fazio VM.

World J Gastroenterol. 2005 Nov 14;11(42):6694-700.

Supplemental Content

Loading ...
Support Center